Drug Enforcement D-237-2013

Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.

Status

Terminated

Classification

Class II

Report Date

April 10, 2013

Termination Date

January 15, 2014

Product Information

Product description
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Product quantity
3 boxes
Reason for recall
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
NC

Location & Firm

Recalling firm
Teva Pharmaceuticals USA, Inc.
Address
650 Cathill Rd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-237-2013
Event ID
64305
Recall initiation date
February 7, 2013
Center classification date
April 1, 2013
Code info
Lot # 32900136A, Exp. 05/14
More code info